RankingsPricing
  1. US-listed companies
  2. IONIS PHARMACEUTICALS INC
  3. Financials
  4. Return on Assets

IONIS PHARMACEUTICALS INCIONS

Market cap
$12.4B
P/E ratio
SummaryFinancials
Period EndReturn on Assets (Million USD)YoY (%)
Dec 31, 2024-15.1+14.25%
Dec 31, 2023-13.3+26.53%
Dec 31, 2022-10.5+819.30%
Dec 31, 2021-1.1-92.90%
Dec 31, 2020-16-256.13%
Dec 31, 201910.3-25.07%
Dec 31, 201813.7-2688.68%
Dec 31, 2017-0.5-94.28%
Dec 31, 2016-9.3+0.33%
Dec 31, 2015-9.2+113.66%
Dec 31, 2014-4.3-50.40%
Dec 31, 2013-8.7-31.47%
Dec 31, 2012-12.7-22.41%
Dec 31, 2011-16.4

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)